You are here

chronic spontaneous urticaria

FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease

Benzinga

Fri, 11/15/24 - 11:15 am

chronic spontaneous urticaria

Celldex reports positive study results in chronic hives

Investing.com

Wed, 09/25/24 - 10:18 pm

chronic spontaneous urticaria

clinical trials

Sanofi looks to advance CSU drug rilzabrutinib in Phase III trial

Clinical Trials Arena

Mon, 02/26/24 - 10:35 am

chronic spontaneous urticaria

clinical trials

Novartis’ urticaria drug meets all endpoints in Phase III trials

Clinical Trials Arena

Fri, 11/10/23 - 10:05 am

chronic spontaneous urticaria

clinical trials

United BioPharma's Study Reveals New Class of Monoclonal Antibody for Effective Relief of Urticaria Symptoms

Drugs.com

Mon, 08/8/22 - 10:28 am

United BioPHarma

chronic spontaneous urticaria

clinical trials

monoclonal antibodies

Sanofi's Dupixent falls short in phase 3 chronic spontaneous urticaria trial

Pharmaforum

Fri, 02/18/22 - 10:40 am

clinical trials

chronic spontaneous urticaria

Blow for Novartis as ligelizumab can’t top Xolair in phase 3

Pharmaforum

Mon, 12/20/21 - 11:01 am

clinical trials

chronic spontaneous urticaria

New Drug Proves to Ease the Itch for Chronic Spontaneous Urticaria

BioSpace

Sat, 07/31/21 - 10:18 pm

clinical trials

chronic spontaneous urticaria

Novartis gets FDA breakthrough therapy status for ligelizumab to treat chronic spontaneous urticaria

Pharmaceutical Business Review

Fri, 01/15/21 - 09:49 am

breakthrough therapy

chronic spontaneous urticaria

Novartis gets EC approval for self-administration of Xolair across all indications

Pharmaceutical Business Review

Fri, 12/14/18 - 02:30 pm

severe allergic asthma

chronic spontaneous urticaria

Novartis' omalizumab shines in third PhIII hives trial

Pharma Times, UK

Mon, 10/7/13 - 08:52 am

chronic spontaneous urticaria